Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis

FASEB Journal

Volumn 13, Issue 13, 1999, Pages 1787-1795

  Haroon, Zishan A ^a   Hettasch, Joann M ^a   Lai, Thung Shenq ^a   Dewhirst, Mark W ^a   Greenberg, Charles S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cross linking; Endothelial cells; Extracellular matrix; TGF ; Tissue repair

Indexed keywords

FIBRIN; INTERLEUKIN 6; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PUNCH BIOPSY; RAT; SKIN FLAP; WOUND HEALING;

ANIMALIA;

EID: 0032824155     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.13.13.1787     Document Type: Article

References (39)

1. Clark, R. A. (1993) Biology of dermal wound repair. Dermatol. Clin. 11, 647-666
2. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31
3. Greenberg, C. S., Birckbichler, P. J., and Rice, R. H. (1991) Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J. 5, 3071-3077
4. Folk, J. E. (1983) Mechanism and basis for specificity of transglutaminase catalyzed epsilon-(gamma-glutamyl) lysine bond formation. Adv. Enzymol. Relat. Areas Mol. Biol. 54, 1-56
5. Barsigian, C., Stern, A. M., and Martinez, J. (1991) Tissue (type II) transglutaminase covalentty incorporates itself, fibrinogen, or fibronectin into high molecular weight complexes on the extracellular surface of isolated hepatocytes, Use of 2-[(2-oxopropyl)thio] imidazolium derivatives as cellular transglutaminase inactivators. J. Biol Chem. 266, 22501-22509
6. Mosher, D. F., and Schad, P. E (1979) Cross-linking of fibronectin to collagen by blood coagulation Factor XIIIa. J. Clin. Invest. 64, 781-787
7. Greenberg, C. S., Achyuthan, K. E., Borowitz, M. J., and Shuman, M. A. (1987) The transglutaminase in vascular cells and tissues could provide an alternate pathway for fibrin stabilization. Blood 70, 702-709
8. Achyuthan, K. E., Rowland, T. C., Birckbichler, P. J., Lee, K. N., Bishop, P. D., and Achyuthan, A. M. (1996) Hierarchies in the binding of human factor XIII, factor XIIIa, and endothelial cell transglutaminase to human plasma fibrinogen, fibrin, and fibronectin. Mol. Cell. Biochem. 162, 43-49
9. Aeschlimann, D., and Paulsson, M. (1991) Cross-linking of laminin-nidogen complexes by tissue transglutaminase. A novel mechanism for basement membrane stabilization. J. Biol. Chem. 266, 15308-153017
10. Prince, C. W., Dickie, D., and Krumdieck, C. L. (1991) Osteopontin, a substrate for transglutaminase and factor XIII activity. Biochem. Biophys. Res. Commun. 177, 1205-12010
11. Sane, D. C., Moser, T. L., Pippen, A. M., Parker, C. J., Achyuthan, K. E., and Greenberg, C. S. (1988) Vitronectin is a substrate for transglutaminases. Biochem. Biophys. Res. Commun. 157, 115-120
12. Fesus, L., Madi, A., Balajthy, Z., Nemes, Z., and Szondy, Z (1996) Transglutaminase induction by various cell death and apoptosis pathways. Experientia 52, 942-949
13. Aeschlimann, D., Mosher, D., and Paulsson, M. (1996) Tissue transglutaminase and factor XIII in cartilage and bone remodeling. Semin. Thromb. Hemost. 22, 437-443
14. Im, M. J., Russell, M. A., and Feng, J. F. (1997) Transglutaminase II: a new class of GTP-binding protein with new biological functions. Cell Signal. 9, 477-482
15. Kong, L., and Korthuis, R. J. (1997) Melanoma cell adhesion to injured arterioles: mechanisms of stabilized tethering. Clin. Exp. Metastasis 15, 426-431
16. Bowness, J. M., Tarr, A. H., and Wong, T. (1988) Increased transglutaminase activity during skin wound healing in rats. Biochim. Biophys. Acta 967, 234-240
17. Bowness, J. M., Henteleff, H., and Dolynchuk, K. N. (1987) Components of increased labelling wilh putrescine and fucose during healing of skin wounds. Connect. Tissue Res. 16, 57-70
18. Dolynchuk, K. N., Bendor-Samuel, R., and Bowness, J. M. (1994) Effect of putrescine on tissue transglutaminase activity in wounds: decreased breaking strength and increased matrix fucoprolein solubility. Plast. Reconstr. Surg. 93, 567-573
19. Papenfuss, H. D., Gross, J. F., Intaglietta, M., and Treese, F. A. (1979) A transparent access chamber for the rat dorsal skin fold. Microvasc. Res. 18, 311-318
20. Lai, T. S., Slaughter, T. F., Koropchak, C. M., Haroon, Z. A., and Greenberg, C. S. (1996) C-terminal deletion of human tissue transglutaminase enhances magnesium-dependent GTP/AT-Pase activity. J. Biol. Chem. 271, 31191-31195
21. Dewhirst, M. W., Vinuya, R. Z., Ong, E. T., Klitzman, B., Rosner, G., Secomb, T. W., and Gross, J. F. (1992) Effects of bradykinin on the hemodynamics of tumor and granulating normal tissue microvasculature. Radiat. Res. 130, 345-354
22. Hsu, S. M., Raine, L., and Fanger, H. (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29, 577-580
23. ε(γ-glutamyl) lysine in benign and malignant human breast lesions: an immunohistochemical study. Int. J. Cancer 48, 215-220
24. ε(γ-glutamyl) lysine levels in fibrin molecules. In Factor XIII, Second International Conference Marburg (McDonagh, J., Seitz, R., and Egbring, R., eds) pp.135-138, Schattauer, Stuttgart, Germany
25. Sheehan, D., and Hrapchak, B. (1980) In Theory and Practice of Histotechnology. Battelle Press, Columbus, Ohio
26. Vollberg, T. M., George, M. D., Nervi, C., and Jetten, A. M. (1992) Regulation of type I and type II transglutaminase in normal human bronchial epithelial and lung carcinoma cells. Am. J. Respir. Cell. Mol. Biol. 7, 10-18
27. Ikura, K., Shinagawa, R., Suto, N., and Sasaki, R. (1994) Increase caused by interleukin-6 in promoter activity of guinea pig liver transglutaminase gene. Biosci. Biotechnol. Biochem. 58, 1540-1541
28. Kuncio, G. S., Tsyganskaya, M., Zhu, J., Liu, S. L., Nagy, L., Thomazy, V., Davies, P. J., and Zern, M. A. (1998). TNF-alpha modulates expression of the tissue transglutaminase gene in liver cells. Am. J. Physiol. 274, G240-G245
29. Nunes, I., Gleizes, P. E., Metz, C. N., and Rifkin, D. B. (1997) Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J. Cell Biol. 136, 1151-1163
30. Gibran, N. S., Heimbach, D. M., and Holbrook, K. A. (1995) Immunolocalization of FXIIIa+ dendritic cells in human burn wounds. J Surg. Res. 59, 378-386
31. Folk, J. E., and Finlayson, J. S. (1977) The epsilon-(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases. Adv. Protein Chem. 31, 1-133
32. Lai, T. S., Achyuthan, K. E., Santiago, M. A., and Greenberg, C. S. (1994) Carboxyl-terminal truncation of recombinant factor XIII A-chains. Characterization of minimum structural requirement for transglutaminase activity. J. Biol. Chem. 269, 24596-24601
33. Valenzuela, R., Shainoff, J. R., DiBello, P. M., Urbanic, D. A., Anderson, J. M., Matsueda, G. R., and Kudryk, B. J. (1992) Immunoelectrophoretic and immunohistochemical characterizations of fibrinogen derivatives in atherosclerotic aortic intimas and vascular prosthesis pseudo-intimas. Am. J. Pathol. 141, 861-880
34. Raghunath, M., Hopfner, B., Aeschlimann, D., Luthi, U., Meuli, M., Altermatt, S., Gobet, R., Bruckner-Tuderman, L., and Steinmann, B. (1996) Cross-linking of the dermo-epidermaljunction of skin regenerating from keratinocyte autografts. Anchoring fibrils are a target for tissue transglutaminase. J. Clin. Invest. 98, 1174-1184
35. Jones, L. N., and Steinen, P. M. (1996) Hair keratinization in health and disease. Dermatol. Clin. 14, 633-650
36. Cohen, I., Gerrard, J. M., and White, J. G. (1982) Ultrastructure of clots during isometric contraction. J. Cell Biol. 93, 775-787
37. Watanabe, Y., and Dvorak, H. F. (1997) Vascular permeability factor/vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation. Exp. Cell Res. 233, 340-349
38. Pepper, M. S. (1997) Transforming growth factor-beta: vasculo-genesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev. 8, 21-43
39. Gallione, C. J., Klaus, D. J., Yeh, E. Y., Stenzel, T. T., Xue, Y., Anthony, K. B., McAllister, K. A., Baldwin, M. A., Berg, J. N., Lux, A., Smith, J. D., Vary, C. P., Craigen, W.J., Westermann, C. J., Warner, M. L., Miller, Y. E., Iackson, C. E., Guttmacher, A. E., and Marchuk, D. A. (1998) Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles. Hum. Mutat. 11, 286-294